Panelists discuss how bempedoic acid offers a promising alternative for patients who are statin-intolerant patients, demonstrating efficacy in reducing major cardiovascular events and low-density lipoproteinLDL cholesterol, while addressing its role in managing residual cardiovascular risk, particularly in high-risk populations.
2 Commerce Drive
Cranbury, NJ 08512